Biostatistical considerations for quality assessment of immunologic measurements used in clinical and longitudinal studies.
Gelman
R
R
Dana Farber Cancer Institute, Boston, Massachusetts 02115.
Eudey
L
L
D002986:Clinical Trials as Topic; D005434:Flow Cytometry / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D007159:Immunologic Tests / Q000592:standards* / Q000706:statistics & numerical data; D007958:Leukocyte Count; D008137:Longitudinal Studies; D008214:Lymphocytes; D011786:Quality Control